Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel Free CAPR Stock Alerts

Capricor Therapeutics (CAPR) Earnings Date, Estimates & Call Transcripts

Capricor Therapeutics logo
$7.18 +0.53 (+7.97%)
As of 02:16 PM Eastern
Compare

Capricor Therapeutics Earnings Summary

Capricor Therapeutics released Q2 2026 earnings on August 14, 2026, reporting an EPS of -$0.70, which missed analysts' consensus estimates of -$0.59 by $0.11. With a trailing EPS of -$2.45, Capricor Therapeutics' earnings are expected to grow next year, from ($1.62) to ($1.20) per share.

Latest Q2
Earnings Date
Aug. 14Estimated
Consensus EPS
(Aug. 14)
-$0.59
Actual EPS
(Aug. 14)
-$0.70 Missed By -$0.11

Q2 2026 Earnings Resources

Powered by Quartr
Get Capricor Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Capricor Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

CAPR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CAPR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Capricor Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20263-$0.59-$0.40-$0.50
Q2 20263-$0.61-$0.42-$0.51
Q3 20263-$0.63$1.40$0.13
Q4 20263-$0.60$2.34$1.00

Capricor Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026-$0.5889-$0.70 -$0.1111-$0.70$2.08M-
5/12/2026Q1 2026-$0.55-$0.59 -$0.04-$0.59$40.00M-
3/12/2026Q4 2025-$0.51-$0.62 -$0.11-$0.62$0.53M-
11/10/2025Q3 2025-$0.54-$0.54--$0.54$0.48M-
8/11/2025Q2 2025-$0.48-$0.57 -$0.09-$0.57$2.60M-
5/13/2025Q1 2025-$0.33-$0.53 -$0.20-$0.53$3.16M$2.73M
3/19/2025Q4 2024-$0.31-$0.16+$0.15-$0.16$9.87M$11.13M

Capricor Therapeutics Earnings - Frequently Asked Questions

Capricor Therapeutics (NASDAQ:CAPR) last announced its quarterly earning data on Friday, August 14, 2026. Learn more on CAPR's earnings history.

In the previous quarter, Capricor Therapeutics (NASDAQ:CAPR) missed the analysts' consensus estimate of ($0.59) by $0.11 with a reported earnings per share (EPS) of ($0.70). Learn more on analysts' earnings estimate vs. CAPR's actual earnings.

The conference call for Capricor Therapeutics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Capricor Therapeutics' latest earnings report can be read online.
Read Transcript

Capricor Therapeutics (NASDAQ:CAPR) has a recorded net income of -$105.04 million. CAPR has generated -$2.45 earnings per share over the last four quarters.

Capricor Therapeutics' earnings are expected to grow from ($1.62) per share to ($1.20) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:CAPR is sourced from Fiscal.ai, with the most recent quarter reported on 8/14/2026. New results are added as companies report their earnings.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...
Decentralized Masters | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel